X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-08-02 | ASMB | Delaney William E IV | Chief Scientific Officer | S - Sale | $1.09 | -9,461 | 142,744 | -6% | -$10,293 | ||||||
2023-08-02 | ASMB | Okazaki Jason A | CEO, Pres | S - Sale | $1.09 | -11,827 | 164,786 | -7% | -$12,867 | ||||||
2023-07-24 | ASMB | Bjorkquist Jeanette M | Principal Accounting Officer | S - Sale | $1.07 | -844 | 26,688 | -3% | -$900 | ||||||
2023-05-30 | ASMB | Delaney William E IV | Chief Scientific Officer | S - Sale | $0.96 | -4,232 | 112,205 | -4% | -$4,046 | ||||||
2023-05-23 | ASMB | McHutchison John G | Dir | S - Sale | $1.04 | -25,972 | 169,160 | -13% | -$27,019 | ||||||
2023-05-23 | ASMB | Bjorkquist Jeanette M | Principal Accounting Officer | S - Sale | $1.04 | -274 | 27,532 | -1% | -$285 | ||||||
2023-05-23 | ASMB | Delaney William E IV | Chief Scientific Officer | S - Sale | $1.04 | -6,561 | 116,437 | -5% | -$6,825 | ||||||
2023-05-23 | ASMB | Okazaki Jason A | CEO, Pres | S - Sale | $1.04 | -6,561 | 126,613 | -5% | -$6,825 | ||||||
2023-03-30 | ASMB | McHutchison John G | Dir | S - Sale | $0.82 | -14,883 | 177,632 | -8% | -$12,252 | ||||||
| D | 2023-03-30 | ASMB | Bjorkquist Jeanette M | Principal Accounting Officer | S - Sale+OE | $0.82 | -774 | 23,806 | -3% | -$637 | |||||
| D | 2023-03-30 | ASMB | Delaney William E IV | Chief Scientific Officer | S - Sale+OE | $0.82 | -3,421 | 85,498 | -4% | -$2,816 | |||||
| D | 2023-03-30 | ASMB | Okazaki Jason A | CEO, Pres | S - Sale+OE | $0.82 | -4,247 | 98,174 | -4% | -$3,496 | |||||
2023-03-27 | ASMB | Okazaki Jason A | CEO, Pres | S - Sale | $1.02 | -4,693 | 102,421 | -4% | -$4,785 | ||||||
2022-08-08 | ASMB | McHutchison John G | CEO | S - Sale | $2.13 | -12,314 | 192,515 | -6% | -$26,200 | ||||||
2022-07-25 | ASMB | Samar Michael P. | CFO | S - Sale | $2.22 | -2,020 | 77,228 | -3% | -$4,479 | ||||||
2022-05-31 | ASMB | Delaney William E IV | Chief Scientific Officer | S - Sale | $1.92 | -4,164 | 76,419 | -5% | -$8,005 | ||||||
| D | 2022-03-30 | ASMB | Samar Michael P. | CFO | S - Sale+OE | $2.17 | -2,285 | 76,748 | -3% | -$4,953 | |||||
| D | 2022-03-30 | ASMB | Stamm Luisa M | Chief Medical Officer | S - Sale+OE | $2.17 | -1,038 | 40,315 | -3% | -$2,250 | |||||
| D | 2022-03-30 | ASMB | Delaney William E IV | Chief Scientific Officer | S - Sale+OE | $2.17 | -1,038 | 78,083 | -1% | -$2,250 | |||||
| D | 2022-03-30 | ASMB | Okazaki Jason A | COO | S - Sale+OE | $2.17 | -1,269 | 94,614 | -1% | -$2,750 | |||||
| D | 2022-03-30 | ASMB | McHutchison John G | CEO, Pres | S - Sale+OE | $2.17 | -4,614 | 204,829 | -2% | -$10,000 | |||||
2022-03-28 | ASMB | Okazaki Jason A | COO | S - Sale | $2.24 | -4,617 | 64,633 | -7% | -$10,363 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |